6DDCT Research Group. The effect of intensive diabetes therapy on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med, 1993,329:977 - 987.
7Grya E A, Galicka-Latala D, Szczudlik A, et al. Etiopatho- genesis of diabetic neuropathy. Praegl Lek,2000,57:727- 731.
4Dyek PJ, Kratz KM, Kames JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, andnephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology, 1993, 43 : 817-824.
5Bertora P, Valla P, Dezuanni E, et al. Prevalence of subclinical neuropathy in diabetic patients: assessment by study of conduction velocity distribution within motor and sensory nerve fibres. J Neurol,1998. 245:81-86.
6Dejgaard A. Pathophysiology and treatment of diabetic neuropathy.Diabet Med, 1998, 15: 97-112.
7Adler AI, Boyko EJ, Ahroni JH, et al. Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study. Diabetes Care, 1997, 20 : 1162-1167.
8Dyck PJ, Davies JL, Wilson DM, et al. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care, 1999,22 : 1479-1486.
9Gooch C, Podwall D. The diabetic neuropathies. Neurologist, 2004,10: 311-322.
10Sumner C J, Sheth S, Griffin JW, et al. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology, 2003, 60 :108-111.
